全文获取类型
收费全文 | 12438篇 |
免费 | 841篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 262篇 |
儿科学 | 386篇 |
妇产科学 | 190篇 |
基础医学 | 1950篇 |
口腔科学 | 384篇 |
临床医学 | 1221篇 |
内科学 | 2159篇 |
皮肤病学 | 309篇 |
神经病学 | 1229篇 |
特种医学 | 551篇 |
外科学 | 1690篇 |
综合类 | 93篇 |
一般理论 | 11篇 |
预防医学 | 774篇 |
眼科学 | 445篇 |
药学 | 879篇 |
中国医学 | 27篇 |
肿瘤学 | 749篇 |
出版年
2023年 | 51篇 |
2021年 | 174篇 |
2020年 | 155篇 |
2019年 | 216篇 |
2018年 | 256篇 |
2017年 | 236篇 |
2016年 | 274篇 |
2015年 | 302篇 |
2014年 | 372篇 |
2013年 | 473篇 |
2012年 | 656篇 |
2011年 | 724篇 |
2010年 | 395篇 |
2009年 | 367篇 |
2008年 | 581篇 |
2007年 | 610篇 |
2006年 | 616篇 |
2005年 | 568篇 |
2004年 | 554篇 |
2003年 | 521篇 |
2002年 | 410篇 |
2001年 | 428篇 |
2000年 | 381篇 |
1999年 | 337篇 |
1998年 | 146篇 |
1997年 | 105篇 |
1996年 | 111篇 |
1995年 | 98篇 |
1994年 | 95篇 |
1993年 | 56篇 |
1992年 | 176篇 |
1991年 | 163篇 |
1990年 | 173篇 |
1989年 | 164篇 |
1988年 | 137篇 |
1987年 | 129篇 |
1986年 | 115篇 |
1985年 | 117篇 |
1984年 | 85篇 |
1983年 | 81篇 |
1982年 | 55篇 |
1980年 | 53篇 |
1979年 | 85篇 |
1978年 | 69篇 |
1977年 | 78篇 |
1975年 | 57篇 |
1974年 | 58篇 |
1973年 | 56篇 |
1972年 | 81篇 |
1938年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
1.
2.
3.
V. Papp A. Iljicsov C. Rajda M. Magyari N. Koch‐Henriksen T. Petersen G. Jakab I. Deme F. Nagy P. Imre Z. Lohner K. Kovcs A. J. Birks . Kves G. Rum Z. Nagy L. Kernyi L. Vcsei K. Bencsik Z. Jobbgy P. Diszeghy L. Horvth G. Galntai J. Kasza G. Molnr M. Sim M. Stori C. Rzsa P. cs T. Berki G. Lovas S. Komoly Z. Illes 《European journal of neurology》2020,27(2):308-317
4.
Ronny Redlich Ilona Schneider Nicole Kerkenberg Nils Opel Jonas Bauhaus Verena Enneking Jonathan Repple Elisabeth J. Leehr Dominik Grotegerd Claas Khler Katharina Frster Katharina Dohm Susanne Meinert Tim Hahn Harald Kugel Kathrin Schwarte Christiane Schettler Katharina Domschke Volker Arolt Walter Heindel Bernhard T. Baune Weiqi Zhang Christa Hohoff Udo Dannlowski 《Human brain mapping》2020,41(3):594-604
Epigenetic alterations of the brain‐derived neurotrophic factor (BDNF) gene have been associated with psychiatric disorders in humans and with differences in amygdala BDNF mRNA levels in rodents. This human study aimed to investigate the relationship between the functional BDNF‐Val66Met polymorphism, its surrounding DNA methylation in BDNF exon IX, amygdala reactivity to emotional faces, and personality traits. Healthy controls (HC, n = 189) underwent functional MRI during an emotional face‐matching task. Harm avoidance, novelty seeking and reward dependence were measured using the Tridimensional Personality Questionnaire (TPQ). Individual BDNF methylation profiles were ascertained and associated with several BDNF single nucleotide polymorphisms surrounding the BDNF‐Val66Met, amygdala reactivity, novelty seeking and harm avoidance. Higher BDNF methylation was associated with higher amygdala reactivity (x = 34, y = 0, z = ?26, t(166) = 3.00, TFCE = 42.39, p(FWE) = .045), whereby the BDNF‐Val66Met genotype per se did not show any significant association with brain function. Furthermore, novelty seeking was negatively associated with BDNF methylation (r = ?.19, p = .015) and amygdala reactivity (r = ?.17, p = .028), while harm avoidance showed a trend for a positive association with BDNF methylation (r = .14, p = .066). The study provides first insights into the relationship among BDNF methylation, BDNF genotype, amygdala reactivity and personality traits in humans, highlighting the multidimensional relations among genetics, epigenetics, and neuronal functions. The present study suggests a possible involvement of epigenetic BDNF modifications in psychiatric disorders and related brain functions, whereby high BDNF methylation might reduce BDNF mRNA expression and upregulate amygdala reactivity. 相似文献
5.
The aim of this review is to collect together the results of the numerous studies over the last two decades on the pharmacological properties of palmatine published in scientific databases like Scopus and PubMed, which are scattered across different publications. Palmatine, an isoquinoline alkaloid from the class of protoberberines, is a yellow compound present in the extracts from different representatives of Berberidaceae, Papaveraceae, Ranunculaceae, and Menispermaceae. It has been extensively used in traditional medicine of Asia in the treatment of jaundice, liver‐related diseases, hypertension, inflammation, and dysentery. New findings describe its possible applications in the treatment of civilization diseases like central nervous system‐related problems. This review intends to let this alkaloid come out from the shade of a more frequently described alkaloid: berberine. The toxicity, pharmacokinetics, and biological activities of this protoberberine alkaloid will be developed in this work. 相似文献
6.
Maria Ricci Agostino Chiaravalloti Alessandro Martorana Giacomo Koch Vincenzo De lucia Gaetano Barbagallo Orazio Schillaci 《Annals of nuclear medicine》2020,34(4):254-262
The aim of our study was to investigate the impact of the epsilon phenotype in brain glucose consumption in a population with Alzheimer’s disease. Statistical Parametric Mapping (SPM8) was used to investigate differences in brain glucose consumption (as detectable by means of 18F FDG-PET/CT) in the population examined. A total of 129 patients (72 females and 57 males) with a diagnosis of probable AD according to the NINCDS-ADRDA criteria underwent the PET/CT examination. The mean (SD) age of the patients was 70 (± 7) years; the mean Mini-Mental State Examination was 19(± 5.6). 59 expressed epsilon 4 phenotype (E4) and 70 expressed the epsilon 3 phenotype (E3). Cerebral spinal fluid amyloid, tau, and t-tau have been measured resulting equal to 367.4 (± 149.1), 584.7 (± 312.1), and 79.2(± 45.9) pg/ml, respectively. Patients with confirmed amyloid and Tau changes were classified as AD. Patients with amyloid changes but negative Tau, considered as high risk of AD, were classified as IAD. Age, sex, MMSE, scholarship, and CSF parameters were used as a covariate in the SPM analyses. We did not find significant differences in age, gender, and MMSE and CSF parameters among groups. In the analysis of the AD group as compared to AD-E3, AD-E4 subjects show a significant reduction of brain glucose consumption in inferior frontal gyrus bilaterally (BA 45, BA 47). In the analysis of the IAD group as compared to IAD-E3, IAD-E4 subjects show a significant reduction of brain glucose consumption in right in medial, middle, and superior frontal gyrus (BA10, BA11), and in left medial and middle frontal gyrus (BA10, BA11). The differences between IAD-E3 and AD-E3 and between IAD-E4 and AD-E4 (and vice versa analysis) resulted not significant. APO-e4 is related to a major involvement of the frontal cortex confirming its role of risk factor in AD, while APO-3 seems not related to a specific pattern, supporting the hypothesis of neutral/protective role in AD. 相似文献
7.
Pulmonary Pulse Transit Time: A Novel Echocardiographic Indicator of Hemodynamic and Vascular Alterations in Pulmonary Hypertension and Pulmonary Fibrosis 下载免费PDF全文
8.
9.
10.